Revelation Biosciences Other Current Liabilities

Revelation Biosciences (REVB) currently reports a other current liabilities of $470K as of March 2026. That compares with $-160K in the prior-year period — up 391.5% year over year. Use the charts on this page to explore Revelation Biosciences's other current liabilities history and peer comparisons.

Revelation Biosciences's other current liabilities increased from $-160K to $470K — a 391.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Revelation Biosciences reported $470K in other current liabilities as of March 2026. That compares with $-160K in the prior-year period — up 391.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $470K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Revelation Biosciences, and consider following REVB for alerts when major investors trade the stock.